Citations

Clear

9383 citation(s) found for "Thomas, PS".

Transmigration of Eosinophils Through Basement Membrane Components In Vitro: Synergistic Effects of Platelet-Activating Factor and Eosinophil-Active Cytokines
Okada, Shinji , Kita, Hirohito , Gleich, G J, Leiferman, Kristin M. , George, Thomas J. , Kita, H

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 16 | Issue: 4 | Pages: 455-463

10.1165/ajrcmb.16.4.9115757 | PMID 9115757 Get It

Abstract Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1α, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by β1- and β2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.
Pneumocystis carinii Contains a Functional Cell-division-cycle Cdc2 Homologue
Thomas, Charles F., Leof, Edward B. , Anders, Robert A. , Gustafson, Michael P. , Limper, Andrew H.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 18 | Issue: 3 | Pages: 297-306

10.1165/ajrcmb.18.3.3122 | PMID 9490647 Get It

Abstract Pneumocystis carinii causes life-threatening pneumonia in immunocompromised patients. The inability to culture P. carinii has hampered basic investigations of the organism's life cycle, limiting the development of new therapies directed against it. Recent investigations indicate that P. carinii is a fungus phylogenetically related to other ascomycetes such as Schizosaccharomyces pombe. The cell cycles of S. pombe and homologous fungi are carefully regulated by cell-division-cycle molecules (cdc), particularly cell-division-cycle 2 (Cdc2), a serine–threonine kinase with essential activity at the G1 restriction point and for entry into mitosis. Antibodies to the proline–serine–threonine–alanine–isoleucine–arginine (PSTAIR) amino-acid sequence conserved in Cdc2 proteins specifically precipitated, from P. carinii extracts, a molecule with kinase activity consistent with a Cdc2-like protein. Cdc2 molecules exhibit differential activity throughout the life cycle of the organisms in which they occur. In accord with this, the P. carinii Cdc2 showed greater specific activity in P. carinii trophic forms (trophozoites) than in spore-case forms (cysts). In addition, complete genomic and complementary DNA (cDNA) sequences of P. carinii Cdc2 were cloned and found to be most closely homologus to the corresponding sequences of other pathogenic fungi. The function of P. carinii cdc2 cDNA was further documented through its ability to complement the DNA of mutant strains of S. pombe with temperature-sensitive deficiencies in Cdc2 activity. The P. carinii cdc2 cDNA restored normal Cdc2 function in these mutant strains of S. pombe, and promoted fungal proliferation. These studies represent the first molecular analysis of the cell-cycle-regulatory machinery in P. carinii. Further understanding of P. carinii's life cycle promises novel insights for preventing and treating the intractable infection it causes in immunocompromised patients.
In Vitro Transport of Active α1-Antitrypsin to the Apical Surface of Epithelia by Targeting the Polymeric Immunoglobulin Receptor
Eckman, Elizabeth A. , Mallender, William D. , Szegletes, T., Silski, Catherine L., Schreiber, John R. , Ferkol, Thomas W. , Davis, Pamela B.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 2 | Pages: 246-252

10.1165/ajrcmb.21.2.3687 | PMID 10423408 Get It

Abstract In cystic fibrosis (CF), the intense host inflammatory response to chronic infection largely accounts for the progressive pulmonary disease, and ultimately death. Neutrophils are the prominent inflammatory cells in the lungs of patients with CF, and large amounts of neutrophil elastase (NE) are released during phagocytosis. Besides having direct effects on structural elastin, NE stimulates the release of proinflammatory mediators from the respiratory epithelium and is a potent secretogogue. Therapeutic use of elastase inhibitors in CF has been complicated by difficulties in delivery to the critical site in the airway—the surface of the epithelium. We describe a unique strategy to protect the respiratory epithelial cell surface directly by capitalizing on the nondegradative transcytotic pathway of the polymeric immunoglobulin receptor (pIgR). A recombinant fusion protein was constructed consisting of an antihuman pIgR single-chain Fv (scFv) antibody linked to human α1-antitrypsin (A1AT), an inhibitor of NE. The recombinant scFv-A1AT fusion protein bound specifically to the pIgR on the basolateral surface of an epithelial cell monolayer, and was transported and released into the apical medium where the A1AT domain was capable of forming an inactivation complex with NE. Thus, A1AT linked to an antihuman pIgR scFv was delivered in receptor-specific fashion from the basolateral to apical surface and was released as an active antiprotease, indicating that it is feasible to deliver therapeutic proteins to the apical surface of epithelia by targeting the pIgR.
Stimulation of Neutrophil Interleukin-8 Production by Eosinophil Granule Major Basic Protein
Page, Scott M., Gleich, Gerald J. , Roebuck, Kenneth A., Thomas, Larry L.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 2 | Pages: 230-237

10.1165/ajrcmb.21.2.3647 | PMID 10423406 Get It

Abstract We evaluated the ability of eosinophil granule major basic protein (MBP) to stimulate interleukin (IL)-8 production by neutrophils. MBP over the concentration range of 0.1 to 10 μM stimulated the release of up to approximately 8 ng/ml IL-8. Incubation with 2 μM MBP showed that, after a 1 h lag, the level of IL-8 release increased with time for approximately 10 h. At the 2 μM concentration, eosinophil cationic protein, eosinophil-derived neurotoxin, and eosinophil peroxidase did not stimulate significant levels of IL-8 production. MBP stimulated 2-fold increases in IL-8 messenger RNA (mRNA) after 1 and 3 h of incubation, which were blocked by pretreatment with actinomycin D. However, stimulation with MBP did not produce an increase in the binding activity of nuclear factor (NF)-κB or activator protein-1. No NF–IL-6 binding activity was detected in the same nuclear extracts. In addition, stimulation with MBP prolonged the stability of IL-8 mRNA. MBP also induced transient increases in mRNA for macrophage inflammatory protein (MIP)-1α and MIP-1β, but did not stimulate the release of either chemokine. These findings indicate that MBP is selective among the eosinophil granule proteins as a stimulus for neutrophil IL-8 release and, further, that stimulation of neutrophil IL-8 release by MBP involves both transcriptional and posttranscriptional regulation. We postulate that MBP-induced release of IL-8 by neutrophils may contribute to the pathophysiology of acute asthma and other inflammatory lung diseases.
Phosphatidylinositol Kinase Regulation of Airway Smooth Muscle Cell Proliferation
Thomas, Charles F., Limper, Andrew H.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 23 | Issue: 4 | Pages: 429-430

10.1165/ajrcmb.23.4.f200 | PMID 11017904 Get It

Pneumocystis carinii Uses a Functional Cdc13 B-Type Cyclin Complex during Its Life Cycle
Thomas, Charles F., Mubarak, Kamal K., Leof, Edward B. , Kottom, Theodore J. , Limper, Andrew H.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 22 | Issue: 6 | Pages: 722-731

10.1165/ajrcmb.22.6.3838 | PMID 10837370 Get It

Abstract Pneumocystis carinii causes severe pneumonia in immunocompromised patients. Recent studies indicate that P. carinii uses a Cdc2 cyclin-dependent kinase to control its proliferation. To further study the regulation of the life cycle of P. carinii, we characterized the P. carinii B-type cyclin termed Cdc13, whose binding to Cdc2 is necessary for kinase activity. Antibodies to B-type cyclins (Cdc13) specifically immunoprecipitated Cdc2/Cdc13 complexes with associated kinase activity from P. carinii extracts. To clone P. carinii cdc13, degenerate polymerase chain reaction was undertaken using primers generated from amino-acid motifs conserved in fungal Cdc13 proteins. This amplicon was used to obtain full-length genomic and complementary DNA (cDNA) clones. A specific synthetic peptide antibody generated to P. carinii Cdc13 further demonstrated differential Cdc2/Cdc13 activity over the life cycle of P. carinii, with greater activity in cysts compared with trophic forms of the organism. Finally, P. carinii cdc13 cDNA was used to rescue mutant Schizosaccharomyces pombe strains containing temperature-sensitive deficiencies of endogenous Cdc13 activity, thus verifying function of the P. carinii Cdc13 protein. Therefore, P. carinii contains a Cdc13 cyclin, which is variably active over its life cycle and which promotes fungal proliferation.
Understanding Nonspecific Interstitial Pneumonia: The Need for a Diagnostic Gold Standard
Colby, Thomas V. , Galvin, J R, Hunninghake, Gary, King, Talmadge E. , Lynch, David A. , Travis, William D.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 3, 2013 | Volume: 179 | Issue: 3 | Pages: 256-256

10.1164/ajrccm.179.3.256 Get It

Surgical Lung Biopsy in the Diagnosis of Idiopathic NSIP: Do We Always Need It in the Initial Approach?
Colby, Thomas V. , Galvin, J R, Hunninghake, Gary, King, Talmadge E. , Lynch, David A. , Travis, William D.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 3, 2013 | Volume: 179 | Issue: 11 | Pages: 1071-1072

10.1164/ajrccm.179.11.1071a | PMID 19458271 Get It

Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
Choquet, Sylvain , Jagadeesh, Deepa , Smith, Sonali M. , Leblond, V., Roy, Rupali, Gordon, Leo I. , Dierickx, Daan , Schiff, David , Evens, Andrew M. , Kroll‐Desrosiers, Aimee , Morschhauser, Franck , BARTON, BRUCE A. , Gandhi, Maher K. , Habermann, Thomas M. , Trappe, Ralf Ulrich , Gordon, Leo I

Mayo Clinic

American Journal of Transplantation | April 3, 2013 | Volume: No volume available | Issue: No issue available | Pages: n/a-n/a

10.1002/ajt.12211 Get It

Symptomatic Amyloid Goiters: Report of Five Cases
Law, Jennie H., Dean, Diana S., Scheithauer, Berndt, Earnest, Franklin, Sebo, Thomas J., Fatourechi, Vahab

Mayo Clinic

Thyroid | April 2, 2013 | Volume: 23 | Issue: 11 | Pages: 1490-1495

10.1089/thy.2012.0431 | PMID 23544771 Get It